Expression profiling of human idiopathic dilated cardiomyopathy

Cardiovascular Research

Volumn 59, Issue 2, 2003, Pages 400-411

  Grzeskowiak, Rafal ^a   Witt, Henning ^a   Drungowski, Mario ^a   Thermann, Rolf ^b   Hennig, Steffen ^a   Perrot, Andreas ^c   Osterziel, Karl J ^c   Klingbiel, Dirk ^a   Scheid, Stefanie ^a   Spang, Rainer ^a   Lehrach, Hans ^a   Ruiz, Patricia ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiac biopsy; Cardiomyopathy; cDNA array; Expression profile; UniGene

Indexed keywords

COMPLEMENTARY DNA; RNA;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL ENERGY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; FETUS; GENE AMPLIFICATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE LIBRARY; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOME; HEART CONTRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; ORGAN DONOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SAMPLING; SCALE UP; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; GENE EXPRESSION PROFILING; GENE LIBRARY; HUMANS; MICE; MICE, TRANSGENIC; MIDDLE AGED; MODELS, ANIMAL; MUSCLE PROTEINS; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 10744224341     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00426-7     Document Type: Article

References (36)

1. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 93:1996;841-842.
2. Olson T.M., Michels V.V., Thibodeau S.N., Tai Y.S., Keating M.T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 280:1998;750-752.
3. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104:2001;557-567.
4. Chien K.R. Stress pathways and heart failure. Cell. 98:1999;555-558.
5. Coral-Vazquez R., Cohn R.D., Moore S.A., et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98:1999;465-474.
6. Hunter J.J., Chien K.R. Mechanisms of disease: signaling pathways for cardiac hypertrophy and failure. New Engl J Med. 341:1999;1276-1283.
7. Olson E.N., Williams R.S. Calcineurin signaling and muscle remodeling. Cell. 101:2000;689-692.
8. Duggan D., Bittner M., Chen Y., Meltzer P., Trent J. Expression profiling using cDNA microarrays. Nat Genet. 21:1999;10-14.
9. Shiffman D., Porter J. Gene expression profiling of cardiovascular disease models. Curr Opin Biotechnol. 11:2000;598-601.
10. Zhu H., Snyder M. Omic' approaches for unraveling signaling networks. Curr Opin Cell Biol. 14:2002;173-179.
11. Yang J., Moravec C.S., Sussman M.A., et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation. 102:2000;3046-3052.
12. Barrans J.D., Stamatiou D., Liew C.C. Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. Biochem Biophys Res Commun. 280:2001;964-969.
13. Barrans J.D., Allen P.D., Stamatiou D., Dzau V.J., Liew C.C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol. 160:2002;2035-2043.
14. Hwang J., Allen P.D., Tseng G.C., et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics. 10:2002;31-44.
15. Aberger F., Costa-Pereira A.P., Schlaak J.F., et al. Analysis of gene expression using high-density and IFN-gamma-specific low-density cDNA arrays. Genomics. 77:2001;50-57.
16. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 22:2001;1527-1560.
17. Eberwine J. Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. Biotechniques. 20:1996;584-591.
18. Arber S., Hunter J.J., Ross J., et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 88:1997;393-403.
19. Altschul S.F., Madden T.L., Schaffer A.A., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
20. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 98:2001;5116-5121.
21. Wang E., Miller L.D., Ohnmacht G.A., Liu E.T., Marincola F.M. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol. 18:2000;457-459.
22. Knoell R., Hoshijima M., Hoffman H.M., et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 111:2003;943-955.
23. Guy P.M., Kenny D.A., Gill G.N. The PDZ domain of the LIM protein enigma binds to beta-tropomyosin. Mol Biol Cell. 10:1999;1973-1984.
24. Durick K., Gill G.N., Taylor S.S. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2. Mol Cell Biol. 18:1998;2298-2308.
25. Chu P.H., Ruiz-Lozano P., Zhou Q., Cai C., Chen J. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev. 95:2000;259-265.
26. Roof D.J., Hayes A., Adamian M., Chishti A.H., Li T. Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. J. Cell Biol. 138:1997;575-588.
27. Faulkner G., Pallavicini A., Formentin E., et al. ZASP: a new Z-band alternatively spliced PDZ-motif protein. J Cell Biol. 146:1999;465-475.
28. Kemp T.J., Sadusky T.J., Simon M., et al. Identification of a novel stretch-responsive skeletal muscle gene (Smpx). Genomics. 72:2001;260-271.
29. Stanley W.C., Chandler M.P. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 7:2002;115-130.
30. Takemoto M., Kusachi S., Urabe N., Inoue K., Tsuji T. Auto-antibody against adenine nucleotide translocator in dilated cardiomyopathy and myocarditis - incidence and relation to cardiac function and morphology. Jpn Circ J. 57:1993;1150-1158.
31. Dorner A., Schulze K., Rauch U., Schultheiss H.P. Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol Cell Biochem. 174:1997;261-269.
32. Chien K.R. Genomic circuits and the integrative biology of cardiac diseases. Nature. 407:2000;227-232.
33. Narula J., Kolodgie F.D., Virmani R. Apoptosis and cardiomyopathy. Curr Opin Cardiol. 15:2000;183-188.
34. Tsujimoto Y., Shimizu S. The voltage-dependent anion channel: an essential player in apoptosis. Biochimie. 84:2002;187-193.
35. Frey N., McKinsey T.A., Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat Med. 6:2000;1221-1227.
36. Frey N., Richardson J.A., Olson E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci USA. 97:2000;14632-14637.